|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,950.00 GBX | -0.41% |
|
+2.44% | +6.88% |
| 06-16 | GSK's Exdensur Wins Canadian Approval for Severe Asthma, Nasal Polyps | MT |
| 06-16 | Saudi Chemical Co. Secures New Medical Marketing Services Deal from GSK Unit | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 1,984 | 2,268 | 2,213 |
| Spread/Res. | -1.71% | -14.02% | -11.88% |
| Spread/Supp. | +2.44% | +9.09% | +14.13% |
| Support | 1,903.5 | 1,787.5 | 1,708.6 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
Select your edition
All financial news and data tailored to specific country editions
